NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200
about
MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signalingBMI1: A Biomarker of Hematologic MalignanciesTargeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI InhibitorsCooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapyRoles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cellsKey nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancerThe role of NANOG transcriptional factor in the development of malignant phenotype of cancer cellsDifferential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells.α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.A major role for microRNAs in glioblastoma cancer stem-like cells.Mechanisms regulating glioma invasion.Sonidegib: First Global Approval.EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities.Emerging from their burrow: Hedgehog pathway inhibitors for cancer.Cancer-Related Triplets of mRNA-lncRNA-miRNA Revealed by Integrative Network in Uterine Corpus Endometrial Carcinoma.The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation.Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment.SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer.The Hedgehog-GLI pathway in embryonic development and cancer: implications for pulmonary oncology therapy.Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker.Translational gap in ongoing clinical trials for glioma.Signaling pathways and mesenchymal transition in pediatric high-grade glioma.Delivery of Sonic Hedgehog Gene Repressed Irradiation-induced Cellular Senescence in Salivary Glands by Promoting DNA Repair and Reducing Oxidative Stress.A micRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial-mesenchymal transition.
P2860
Q26740198-8133D0E9-EE46-4744-8FA5-ED0DCD4FD299Q26750676-F67B4327-281E-4059-A8EE-B4DD2D28CBCEQ26764892-CB91F7F0-E54F-4FA0-931C-FB7DF9696F70Q26865136-4F864144-A5CE-4124-B9BC-FA7B78FA81EDQ28072650-CCA6BA0D-C6DC-4A57-B069-249DC6BBF2BEQ28082679-E580582F-711B-4D5F-A3CB-8FE8FC1F1760Q28085385-74368478-35EF-48E0-A6D6-A9FF13E7EFE0Q33911224-784A7FDC-0C48-4FD6-BD8E-FCACC0F05BD5Q36545873-022C75F6-8A19-4755-90D9-CF6C970005C1Q36679410-E5632C5D-1A12-4417-AF50-7A690B1F9F52Q37254268-8CA204DB-1F5F-46F0-96FC-48B751B49A81Q37681322-3A03DD77-F3B3-4064-BEF8-2268036FE510Q38356196-3431E004-A300-484E-8D0C-C2509E87AE0DQ38386429-EC21F23F-9FBA-4E23-8D79-ADE982D5C016Q38577307-56EF9BA9-63BF-4CA0-9F00-22FB851DE4DEQ38677439-9F7EF03F-D98B-45D5-BA5E-BE30F931BF99Q38908981-B4451D23-3BDF-4042-9171-5BC4541FC166Q38915810-C14C471A-B987-448D-947F-265173C5158CQ38951799-6DFB46DD-89A9-4AAC-A3BC-BC6AF85E9CC5Q39991268-37A5CA90-99B6-4D15-829C-9F71428B8CA5Q41479717-76905D06-E10D-42B6-9214-1FF853AE631CQ41694131-A53B1643-6BA7-4072-8DD5-284D0EC98FC9Q41912339-5BB3F90B-0989-4790-B47E-692A3647A708Q42323432-3FBA20BF-A8D4-4BEC-B8C6-C92DF88205A8Q48002716-B53C2300-08C2-4820-92E5-D705FA613737Q48258004-F686F0EF-5B61-40DD-8D22-9CCBA052E431Q49981940-6EDCFBFC-98E9-4162-B548-E61CACC85720Q50006155-8A011FFF-0EDB-48E8-B89F-949C27D139D6
P2860
NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
NPV-LDE-225 (Erismodegib) inhi ...... g miR-21, miR-128, and miR-200
@en
type
label
NPV-LDE-225 (Erismodegib) inhi ...... g miR-21, miR-128, and miR-200
@en
prefLabel
NPV-LDE-225 (Erismodegib) inhi ...... g miR-21, miR-128, and miR-200
@en
P2093
P2860
P356
P1433
P1476
NPV-LDE-225 (Erismodegib) inhi ...... g miR-21, miR-128, and miR-200
@en
P2093
Daniel Meeker
Junsheng Fu
Mariana Rodova
Peter J Van Veldhuizen
Rajesh Nanta
Rakesh K Srivastava
Sharmila Shankar
P2860
P304
P356
10.1093/NEUONC/NOT011
P577
2013-03-12T00:00:00Z